SETD1B-associated neurodevelopmental disorder
- 16 June 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 58 (3), 196-204
- https://doi.org/10.1136/jmedgenet-2019-106756
Abstract
Background Dysfunction of histone methyltransferases and chromatin modifiers has been implicated in complex neurodevelopmental syndromes and cancers. SETD1B encodes a lysine-specific methyltransferase that assists in transcriptional activation of genes by depositing H3K4 methyl marks. Previous reports of patients with rare variants in SETD1B describe a distinctive phenotype that includes seizures, global developmental delay and intellectual disability. Methods Two of the patients described herein were identified via genome-wide and exome-wide testing, with microarray and research-based exome, through the CAUSES (Clinical Assessment of the Utility of Sequencing and Evaluation as a Service) Research Clinic at the University of British Columbia. The third Vancouver patient had clinical trio exome sequencing through Blueprint Genetics. The fourth patient underwent singleton exome sequencing in Nantes, with subsequent recruitment to this cohort through GeneMatcher. Results Here we present clinical reports of four patients with rare coding variants in SETD1B that demonstrate a shared phenotype, including intellectual disability, language delay, conserved musculoskeletal findings and seizures that may be treatment-refractory. We include supporting evidence from next-generation sequencing among a cohort of paediatric patients with epilepsy. Conclusion Rare coding variants in SETD1B can cause a diagnosable syndrome and could contribute as a risk factor for epilepsy, autism and other neurodevelopmental phenotypes. In the long term, some patients may also be at increased risk for cancers and other complex diseases. Thus, longitudinal studies are required to further elucidate the precise role of SETD1B in neurodevelopmental disorders and other systemic disease.Keywords
Funding Information
- BC Children's Hospital Intramural Funding
- Canadian Institute of Health Research (Project Grant PJT-148695, Project Grant PJT-148830)
This publication has 31 references indexed in Scilit:
- Report on a Patient with a 12q24.31 Microdeletion Inherited from an Insulin-Dependent Diabetes Mellitus FatherMolecular Syndromology, 2013
- Rbm15-Mkl1 Interacts with the Setd1b Histone H3-Lys4 Methyltransferase via a SPOC Domain That Is Required for Cytokine-Independent ProliferationPLOS ONE, 2012
- Structural Basis for WDR5 Interaction (Win) Motif Recognition in Human SET1 Family Histone MethyltransferasesOnline Journal of Public Health Informatics, 2012
- Nuclear Matrix Factor hnRNP U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 snRNP MaturationMolecular Cell, 2012
- Clinical application of 2.7M Cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disabilityClinical Genetics, 2012
- Mutations in EZH2 Cause Weaver SyndromeAmerican Journal of Human Genetics, 2012
- AnimalTFDB: a comprehensive animal transcription factor databaseNucleic Acids Research, 2011
- A Microdeletion at 12q24.31 Can Mimic Beckwith-Wiedemann Syndrome NeonatallyMolecular Syndromology, 2010
- Structural Basis for the Requirement of Additional Factors for MLL1 SET Domain Activity and Recognition of Epigenetic MarksMolecular Cell, 2009
- Identification and Characterization of the Human Set1B Histone H3-Lys4 Methyltransferase ComplexJournal of Biological Chemistry, 2007